United Therapeutics Buys Lexington Clean Rooms Facility
A publicly traded life science company acquired a clean rooms facility in Lexington from Brammer Bio for $21.5 million.
A publicly traded life science company acquired a clean rooms facility in Lexington from Brammer Bio for $21.5 million.
A contract biomanufacturer says a planned redevelopment by Boston Properties could disrupt its current and future business if the Kendall Square property where it has invested $100 million since 2017 is demolished.
A former warehouse on Pleasant Street in Watertown will provide 80,000 square feet of development and manufacturing space for life science companies following a conversion project.
Officials want to attract more life science and advanced manufacturing firms to the Route 3 North area to shore up tax bases, but developers are pushing housing.
A Chelmsford flex portfolio occupied by such tenants as Endeavor Robotics and Thermo Fisher Scientific has been sold for $15.75 million to a Springfield investor.